Abstract
Tubulin represents a potent target in cancer chemotherapy. Combretastatin is a naturally occurring well known tubulin polymerization inhibitor. Combretastatin and its analogues have been discussed in this review in detail. For better understanding, this review is subdivided as per the carbon distance between to the two aromatic rings. Under these heading, various synthetic analogues, general synthetic route, their brief SAR and structures of the most potent compound has been discussed. This article will be a good platform to guide the chemist to design and synthesize drug like molecules for tubulin polymerization inhibitory potential with optimized pharmacokinetic profile.
Keywords: Anticancer, antiproliferative, combretastatin analogues, combretastatin, microtubule binding agents, tubulin binding agents.
Graphical Abstract
Current Organic Chemistry
Title:A Comprehensive Review on Combretastatin Analogues as Tubulin Binding Agents
Volume: 18 Issue: 19
Author(s): Rupinder K. Gill, Ramandeep Kaur, Gurneet Kaur, Ravindra K. Rawal, Anamik K. Shah and Jitender Bariwal
Affiliation:
Keywords: Anticancer, antiproliferative, combretastatin analogues, combretastatin, microtubule binding agents, tubulin binding agents.
Abstract: Tubulin represents a potent target in cancer chemotherapy. Combretastatin is a naturally occurring well known tubulin polymerization inhibitor. Combretastatin and its analogues have been discussed in this review in detail. For better understanding, this review is subdivided as per the carbon distance between to the two aromatic rings. Under these heading, various synthetic analogues, general synthetic route, their brief SAR and structures of the most potent compound has been discussed. This article will be a good platform to guide the chemist to design and synthesize drug like molecules for tubulin polymerization inhibitory potential with optimized pharmacokinetic profile.
Export Options
About this article
Cite this article as:
Gill K. Rupinder, Kaur Ramandeep, Kaur Gurneet, Rawal K. Ravindra, Shah K. Anamik and Bariwal Jitender, A Comprehensive Review on Combretastatin Analogues as Tubulin Binding Agents, Current Organic Chemistry 2014; 18 (19) . https://dx.doi.org/10.2174/138527281819141028114428
DOI https://dx.doi.org/10.2174/138527281819141028114428 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Thymidine Phosphorylase in Biomodulation of Fluoropyrimidines
Current Pharmaceutical Biotechnology Targeting Schistosome Histone Modifying Enzymes for Drug Development
Current Pharmaceutical Design Naphthalimides and Azonafides as Promising Anti-Cancer Agents
Current Medicinal Chemistry Targeting HOTAIR induces mitochondria related apoptosis and inhibits tumor growth in head and neck squamous cell carcinoma in vitro and in vivo.
Current Molecular Medicine Molecular Targeting of Protein Kinases to Optimize Selectivity and Resistance Profiles of Kinase Inhibitors
Current Topics in Medicinal Chemistry Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery
Current Medicinal Chemistry A Simple and Reliable Approach for Assessing Anticancer Activity In Vitro
Current Medicinal Chemistry Molecular Pathogenesis of Philadelphia-Positive Chronic Myeloid Leukemia – is it all BCR-ABL?
Current Cancer Drug Targets Coumarin Hybrids: Promising Scaffolds in the Treatment of Breast Cancer
Mini-Reviews in Medicinal Chemistry HER2 in the Era of Molecular Medicine: A Review
Current Cancer Therapy Reviews Analgesic and Anti-Inflammatory Properties of Arylnitroalkenes
Inflammation & Allergy - Drug Targets (Discontinued) Tumor Vasculature Targeting Through NGR Peptide-Based Drug Delivery Systems
Current Pharmaceutical Biotechnology Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics L1 Retrotransposon and Retinoblastoma: Molecular Linkages Between Epigenetics and Cancer
Current Molecular Medicine Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies Use of Anticancer Platinum Compounds in Combination Therapies and Challenges in Drug Delivery
Current Medicinal Chemistry Plants vs. Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability
Anti-Cancer Agents in Medicinal Chemistry Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal Chemistry Hypertension in the Elderly: An Evidence-based Review
Current Pharmaceutical Design